AMANDA BUNDY: Open Payments
NPI 1063049963 · JEFFERSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 36 payments from 16 companies in 2025. Trend: 2023 $376 · 2024 $319 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $106 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $96 |
| Ardelyx, Inc. | 3 | $81 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Lilly USA, LLC | 3 | $48 |
| ABBVIE INC. | 3 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Amgen Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $25 |
Products named: XIFAXAN, IBSRELA, VOQUEZNA, MOUNJARO, Wegovy, VRAYLAR, REXULTI, CAPLYTA.
Industry payments across NC — which companies pay providers there.
